EFFICACY AND SAFETY OF UPADACITINIB IN TNFI INADEQUATE RESPONDERS WITH RHEUMATOID ARTHRITIS FROM THREE PHASE 3 CLINICAL TRIALS

被引：0

作者：

Fleischmann, Roy ^{[1
]}

Bessette, Louis ^{[2
]}

Hall, Stephen ^{[3
,4
]}

Sparks, Jeffrey ^{[5
]}

Jain, Manish ^{[6
]}

Kakehasi, Adriana ^{[7
]}

Song, Yanna ^{[8
]}

Meerwein, Sebastian ^{[8
]}

DeMasi, Ryan ^{[8
]}

Suboticki, Jessica ^{[8
]}

Rubbert-Roth, Andrea ^{[9
]}

机构：

[1] Metroplex Clin Res Ctr, Rheumatol, Dallas, TX USA

[2] Laval Univ, Div Rheumatol, Dept Med, Quebec City, PQ, Canada

[3] Monash Univ, Rheumatol, Melbourne, Australia

[4] Emeritus Res, Melbourne, Australia

[5] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA USA

[6] Great Lakes Clin Trials, Rheumatol, Chicago, IL USA

[7] Univ Fed Minas Gerais, Hosp Clin, Rheumatol, Belo Horizonte, Brazil

[8] AbbVie Inc, Immunol, Chicago, IL USA

[9] Cantonal Clin St Gallen, Div Rheumatol, St Gallen, Switzerland

来源：

RHEUMATOLOGY | 2023年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P135

引用

页数：2

共 50 条

[1] EFFICACY AND SAFETY OF UPADACITINIB IN TNFI-IR PATIENTS WITH RHEUMATOID ARTHRITIS FROM THREE PHASE 3 CLINICAL TRIALS
Fleischmann, R. M.
Bessette, L.
Sparks, J.
Hall, S.
Jain, M.
Kakehasi, A.
Song, Y.
Meerwein, S.
Demasi, R.
Suboticki, J.
Rubbert-Roth, A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 618 - 619
[2] Efficacy and Safety of Upadacitinib in TNFi-IR Patients with Rheumatoid Arthritis from Three Phase 3 Clinical Trials
Fleischmann, Roy
Bessette, Louis
Sparks, Jeffrey
Hall, Stephen
Jain, Manish
Kakehasi, Adriana
Song, Yanna
Meerwein, Sebastian
DeMasi, Ryan
Suboticki, Jessica
Rubbert-Roth, Andrea
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 541 - 543
[3] Efficacy and safety of upadacitinib in TNFi-IR patients with rheumatoid arthritis from three Phase 3 clinical trials
Fleischmann, Roy
Bessette, Louis
Sparks, Jeffrey
Hall, Stephen
Jain, Manish
Kakehasi, Adriana
Song, Yanna
Meerwein, Sebastian
DeMasi, Ryan
Suboticki, Jessica
Rubbert-Roth, Andrea
SWISS MEDICAL WEEKLY, 2022, 152 : 14S - 16S
[4] SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE
Fleischmann, Roy
Meerwein, Sebastian
Charles-Schoeman, Christina
Combe, Bernard
Hall, Stephen
Khan, Nasser
Carter, Kyle
Camp, Heidi
Rubbert-Roth, Andrea
INTERNAL MEDICINE JOURNAL, 2023, 53 : 43 - 43
[5] Efficacy and Safety of Upadacitinib in Patients Across Races with Rheumatoid Arthritis: A Post Hoc Analysis of Six Phase 3 Clinical Trials
Wright, Grace
Mysler, Eduardo
Navarro-Millan, Iris
Tanaka, Yoshiya
Anyanwu, Samuel
Liu, Jianzhong
Tanjinatus, Oishi
Garrison, Andrew
Wells, Alvin
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 548 - 550
[6] IMPACT OF CONCOMITANT GLUCOCORTICOIDS ON THE CLINICAL EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN AD HOC ANALYSIS OF DATA FROM THREE PHASE 3 STUDIES
Ostor, Andrew
Combe, Bernard
Buttgereit, Frank
Xavier, Ricardo
Saraux, Alain
Daridon, Capucine
Famulla, Kirsten
Song, Yanna
Lagunes-Galindo, Ivan
Burmester, Gert
INTERNAL MEDICINE JOURNAL, 2021, 51 : 36 - 37
[7] IMPACT OF CONCOMITANT GLUCOCORTICOIDS ON THE CLINICAL EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN AD HOC ANALYSIS OF DATA FROM THREE PHASE 3 STUDIES
Combe, B.
Buttgereit, F.
Ostor, A.
Xavier, R.
Saraux, A.
Daridon, C.
Famulla, K.
Song, Y.
Lagunes-Galindo, I.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 567 - 568
[8] Impact of Concomitant Glucocorticoids on the Clinical Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: An Ad Hoc Analysis of Data from Three Phase 3 Studies
Combe, Bernard
Buttgereit, Frank
Ostor, Andrew
Xavier, Ricardo
Saraux, Alain
Daridon, Capucine
Famulla, Kirsten
Song, Yanna
Lagunes-Galindo, Ivan
Burmester, Gerd
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[9] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
Cohen, Stanley B.
van Vollenhoven, Ronald
Winthrop, Kevin
Zerbini, Cristiano
Tanaka, Yoshiya
Bessette, Louis
Li Yihan
Khan, Nasser
Hendrickson, Barbara
Burmester, Gerd Ruediger
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 357 - 357
[10] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAMME
Cohen, Stanley B.
van Vollenhoven, Ronald
Winthrop, Kevin
Zerbini, Cristiano
Tanaka, Yoshiya
Bessette, Louis
Zhang, Ying
Khan, Nasser
Hendrickson, Barbara
Enejosa, Jeffrey V.
Burmester, Gerd Rudiger
RHEUMATOLOGY, 2020, 59 : 96 - 96

← 1 2 3 4 5 →